The SAGE meeting of 17-19 April 2018 was held at the Centre International de Conférence (CICG) in Geneva. Available on this site you will find meeting information, background reading materials and presentations made at the meeting. The conclusions and recommendations of SAGE meeting are published in the WHO Weekly Epidemiological Record in English and French within two months of each SAGE meeting.
Meeting materials
Related
SAGE Yellow Book for April 2018
SAGE tracking record of recommendations and action points
Report of the EMRO Regional Immunization Technical Advisory Group Meeting, Muscat, Oman - 14 December 2017
Report of the AFRO Regional Immunization Technical Advisory Group Meeting Johannesburg, South Africa - 5–7 December 2017
Meeting Report: 26th Meeting Of The Technical Advisory Group On Immunization And Vaccine-Preventable Diseases In The Western Pacific Region - 13–16 June 2017 Manila, Philippines
Global report including key updates and challenges from regions - M. Friede
No background documents provided for this session.
Malaria vaccine implementation programme (MVIP)
Executive summary Malaria vaccine implementation programme (MVIP)
Progress update Framework for policy decision on the RTS,S/AS01 malaria vaccine: Rationale and process
Overview of the MVIP - F. Were
Current status, pilot country readiness and timelines - G. Bonsu Framework for policy decision - M. Hamel
Executive Summary: Polio the last mile
15th Meeting of the SAGE Polio Working Group - Conclusions and recommendations: Note for the Record - 20-21 February 2018
Responding to a poliovirus event or outbreak: Standard Operating Procedures (SOPs) - January 2019
Polio Post-Certification Strategy: A risk mitigation strategy for a polio-free world
Overview of the Global Polio Eradication Initiative - M. Zaffran
Executive summary on dengue for SAGE
Background paper on dengue vaccines: revision to the background paper from 17 march 2016 (updated April 2018) - Prepared by the sage working group on dengue vaccines and who secretariat - 23 March 2018
Appendix 1: SAGE working group on dengue vaccines and vaccination (December 2017 to August 2018)
Global dengue burden and future projections
Dengue vaccine: Recap and Update on Clinical Trial Results - P. Smith
Modelling population level vaccine impact and coverage rates - N. Ferguson
Biological Standardization: Sixty-eighth report of the Expert Committee on Biological Standardization (ECBS), Geneva - 17-20 October 2017
Global Advisory Committee on Vaccine Safety (GACVS), 6–7 December 2017
Immunization and Vaccines Related Advisory Committee (IVIR-AC) - R. Breiman
Expert Committee on Biological Standardization (ECBS) - K. Cichutek
Global Advisory Committee on Vaccine Safety (GACVS) - R. Pless
Exploration of future immunization policies for measles and rubella: The need for continued investment and the potential benefits of eradication
Annex for presentation by Kimberly M. Thompson, Kid Risk, Inc. on the measles and rubella investment case
WER: Progress towards regional measles elimination – worldwide, 2000–2016
WER: Roadmap to elimination-standard measles and rubella surveillance
Full Public Health Value Propositions for Vaccines: Execuive summary
Estimating the full public health value of vaccination, Vaccine publication, 2017
The broader economic impact of vaccination: reviewing and appraising the strength of evidence, BMC Medicine publication, 2015
WHO full public health value proposition (FPHVP) for vaccines
The public health value of vaccines beyond efficacy: methods, measures and outcomes, BMC Medicine publication, 2017
Session Introduction - A. Cravioto